Tag: biopsy devices market size

  • Biopsy Devices Market Research 2026: Market Size, Trends, Segments And Growth Forecast

    Biopsy Devices Market Research 2026: Market Size, Trends, Segments And Growth Forecast

    Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

    Biopsy Devices Market Revenue Growth On Track For A 8.8% CAGR Through 2030

    The biopsy devices market has experienced substantial growth in recent years. Projections indicate its value will increase from $3.24 billion in 2025 to $3.53 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.1%. This historical development is primarily due to several factors, including an increase in cancer screening rates, the proliferation of diagnostic imaging centers, a greater adoption of biopsy procedures for early detection, the introduction of sophisticated imaging technologies, and enhanced diagnostic capacities within hospitals.

    The biopsy devices market is projected to experience robust expansion in the coming years. It is anticipated to reach $4.95 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.8%. This growth during the forecast period is primarily driven by the increasing integration of AI-assisted biopsy guidance, a rising demand for outpatient diagnostic procedures, the expansion of precision oncology practices, a growing emphasis on early disease detection, and increasing investments in advanced biopsy technologies. Key trends anticipated in this period include the wider adoption of image-guided biopsy systems, a rising use of minimally invasive biopsy techniques, a growing demand for precision sampling devices, the expansion of automated biopsy guidance technologies, and an enhanced focus on diagnostic accuracy.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=44223154&type=smp&name=Biopsy%20Devices%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

    Biopsy Devices Market Growth Momentum: What Factors Are Shaping Demand?

    The anticipated increase in surgical procedures is projected to fuel the expansion of the biopsy devices market. Surgery encompasses a medical field dedicated to treating injuries, diseases, and diverse conditions using both manual techniques and specialized instruments. During surgical operations, biopsy tools are commonly utilized to obtain a small tissue specimen or cell collection for later examination in a laboratory. For example, data from July 2025, provided by the American Med Spa Association (a US-based entity offering legal, compliance, and business support for medical spas and aesthetic practices), indicates a 42.5% surge in cosmetic procedure volumes over the last four years, amounting to 20.5 million non-surgical treatments and 17.4 million surgical procedures by 2024. Consequently, the rising volume of surgeries is propelling the future growth of the biopsy devices market.

    Biopsy Devices Market Segment Analysis And Revenue Potential

    The biopsy devices market covered in this report is segmented –

    1) By Product Type: Needle-Based Biopsy Guns, Biopsy Forceps, Biopsy Guidance Systems, Biopsy Needles, Other Products

    2) By Image Guiding Technology: MRI-Guided Biopsy, Stereotactic-Guided Biopsy, Ultrasound-Guided Biopsy, Other Imaging Technologies

    3) By Application: Breast Biopsy, Gynecological Biopsy, Prostate Biopsy, Blood Cancers Biopsy, Skin Biopsy, Kidney Biopsy, Gastroenterology Biopsy, Other Applications

    4) By End User: Diagnostics And Imaging Centers, Hospitals, Other End User

    Subsegments:

    1) By Needle-Based Biopsy Guns: Spring-Loaded Biopsy Guns, Vacuum-Assisted Biopsy Guns

    2) By Biopsy Forceps: Endoscopic Biopsy Forceps, Surgical Biopsy Forceps

    3) By Biopsy Guidance Systems: Ultrasound-Guided Biopsy Systems, CT-Guided Biopsy Systems, MRI-Guided Biopsy Systems

    4) By Biopsy Needles: Core Needles, Fine Needle Aspiration (FNA) Needles, Coaxial Needles

    5) By Other Products: Biopsy Sutures, Biopsy Markers, Biopsy Storage Solutions

    Biopsy Devices Market Trends Redefining Industry Growth

    Major companies operating in the biopsy devices market are increasingly focused on developing advanced solutions, such as fine-needle biopsy precision technology, to enhance diagnostic accuracy and improve sample quality. This technology pertains to the creation of needles with specialized tips and durable materials designed to optimize tissue extraction while preserving cellular architecture, thereby supporting dependable pathology analysis. For instance, in October 2025, Olympus, a Japan-based medical-technology company, introduced its SecureFlex single-use fine-needle biopsy device, which features nitinol construction and a dual-beveled Raptor Tip. This tip facilitates the collection of larger, intact tissue specimens by minimizing tissue escape and boosting puncture performance. The device’s construction also includes a multi-layer sheath, enabling consistent access to complex anatomical structures like the pancreatic head and uncinate process without the need for frequent scope adjustments. SecureFlex supports fine-needle biopsy via EUS-FNB for gastrointestinal lesions, allowing physicians to obtain high-quality tissue for precise diagnosis and treatment planning. This device contributes to improved sample quality, procedural efficiency, and safety in endoscopic biopsy procedures.

    Biopsy Devices Market Top Companies Driving Competitive Growth

    Major companies operating in the biopsy devices market are Becton Dickinson and Company, Hologic Inc, Boston Scientific Corporation, Cook Medical LLC, Argon Medical Devices Inc, Olympus Corporation, Medtronic plc, Stryker Corporation, B Braun Melsungen AG, INRAD Inc, TSK Laboratory, Mauna Kea Technologies, Veran Medical Technologies, Merit Medical Systems Inc, ConMed Corporation, DTR Medical, Gallini Srl, TransMed7 LLC, MDL Srl, Biopsybell Srl

    View The Full Biopsy Devices Market Report:

    https://thebusinessresearchcompany.com/report/biopsy-devices-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

    Biopsy Devices Market Global Footprint: Which Region Leads The Industry?

    North America was the largest region in the biopsy devices market in 2025. Asia-Pacific was the second largest region in the global biopsy devices market report share. The regions covered in the biopsy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Biopsy Devices Market Trends And Growth Outlook Across The 2026–2030 Forecast Period

    Biopsy Devices Market Trends And Growth Outlook Across The 2026–2030 Forecast Period

    The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

    What Growth In Market Value Is Anticipated For The Biopsy Devices Market Between 2026 And 2030?

    The biopsy devices market has experienced robust expansion in recent years. This market is expected to increase from $3.24 billion in 2025 to $3.53 billion in 2026, at a compound annual growth rate (CAGR) of 9.1%. The historical market expansion is linked to an increase in cancer screening rates, the proliferation of diagnostic imaging centers, greater utilization of biopsy procedures for early diagnosis, the availability of advanced imaging technologies, and the enhancement of diagnostic capabilities within hospitals.

    The biopsy devices market size is projected to experience substantial expansion over the upcoming years. Its value is anticipated to reach $4.95 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.8%. This projected growth is driven by several factors, including the increasing integration of AI-assisted biopsy guidance, a surge in demand for outpatient diagnostic procedures, the broadening scope of precision oncology practices, a heightened emphasis on early disease detection, and increased capital flow into advanced biopsy technologies. Key trends anticipated during this period involve the wider acceptance of image-guided biopsy systems, a growing preference for minimally invasive biopsy techniques, an escalating need for precise sampling devices, the proliferation of automated biopsy guidance technologies, and an intensified commitment to diagnostic accuracy.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3283&type=smp

    Which Strategic Drivers Are Supporting The Biopsy Devices Market Development?

    An increasing number of surgeries is projected to drive the expansion of the biopsy devices market. Surgery is a medical field dedicated to treating injuries, illnesses, and various disorders using both manual and instrumental approaches. In surgical procedures, biopsy devices are frequently used to extract a small tissue sample or a collection of cells for subsequent laboratory examination. For instance, in July 2025, the American Med Spa Association, a US-based provider of legal, compliance, and business resources for medical spas and medical aesthetic practices, reported that cosmetic procedure volumes rose by 42.5% over the past four years, reaching 20.5 million non-surgical treatments and 17.4 million surgical procedures in 2024. Therefore, the growing number of surgeries is propelling the growth of the biopsy devices market going forward.

    How Are Different Segment Groups Identified Within The Biopsy Devices Market?

    The biopsy devices market covered in this report is segmented –

    1) By Product Type: Needle-Based Biopsy Guns, Biopsy Forceps, Biopsy Guidance Systems, Biopsy Needles, Other Products

    2) By Image Guiding Technology: MRI-Guided Biopsy, Stereotactic-Guided Biopsy, Ultrasound-Guided Biopsy, Other Imaging Technologies

    3) By Application: Breast Biopsy, Gynecological Biopsy, Prostate Biopsy, Blood Cancers Biopsy, Skin Biopsy, Kidney Biopsy, Gastroenterology Biopsy, Other Applications

    4) By End User: Diagnostics And Imaging Centers, Hospitals, Other End User

    Subsegments:

    1) By Needle-Based Biopsy Guns: Spring-Loaded Biopsy Guns, Vacuum-Assisted Biopsy Guns

    2) By Biopsy Forceps: Endoscopic Biopsy Forceps, Surgical Biopsy Forceps

    3) By Biopsy Guidance Systems: Ultrasound-Guided Biopsy Systems, CT-Guided Biopsy Systems, MRI-Guided Biopsy Systems

    4) By Biopsy Needles: Core Needles, Fine Needle Aspiration (FNA) Needles, Coaxial Needles

    5) By Other Products: Biopsy Sutures, Biopsy Markers, Biopsy Storage Solutions

    Which Trends Are Affecting The Biopsy Devices Market Framework?

    Major companies in the biopsy devices market are concentrating on developing advanced solutions, including fine-needle biopsy precision technology, to enhance diagnostic accuracy and sample quality. Fine-needle biopsy precision technology describes the creation of needles with specialized tips and robust materials that improve tissue extraction while preserving cell architecture, thus supporting reliable pathology analysis. For instance, in October 2025, Olympus, a Japan-based medical-technology company, launched its SecureFlex single-use fine-needle biopsy device, which incorporates nitinol construction and a dual-beveled Raptor Tip. This tip assists in collecting larger, intact tissue specimens by minimizing tissue escape and improving puncture performance. The construction also features a multi-layer sheath, enabling consistent access to complex anatomical structures like the pancreatic head and uncinate process without frequent scope adjustments. SecureFlex facilitates fine-needle biopsy via EUS-FNB for gastrointestinal lesions and allows physicians to obtain high-quality tissue for precise diagnosis and treatment planning. The device contributes to improved sample quality, procedural efficiency, and safety in endoscopic biopsy procedures.

    Which Companies Are Engaged In The Biopsy Devices Market Environment?

    Major companies operating in the biopsy devices market are Becton Dickinson and Company, Hologic Inc, Boston Scientific Corporation, Cook Medical LLC, Argon Medical Devices Inc, Olympus Corporation, Medtronic plc, Stryker Corporation, B Braun Melsungen AG, INRAD Inc, TSK Laboratory, Mauna Kea Technologies, Veran Medical Technologies, Merit Medical Systems Inc, ConMed Corporation, DTR Medical, Gallini Srl, TransMed7 LLC, MDL Srl, Biopsybell Srl

    Access The Complete Biopsy Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

    Which Region Has The Strongest Presence In The Biopsy Devices Market?

    North America was the largest region in the biopsy devices market in 2025. Asia-Pacific was the second largest region in the global biopsy devices market report share. The regions covered in the biopsy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access a Customized Biopsy Devices Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/customise?id=3283&type=smp

    Browse Through More Reports Similar to the Global Biopsy Devices Market 2026, By The Business Research Company

    Biopsy Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

    Smart Biopsy Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

    Liquid Biopsy Market Report 2026

    https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Biopsy Devices Market Forecast 2026–2035 Highlighting Market Data Patterns and Industry Insights

    Biopsy Devices Market Forecast 2026–2035 Highlighting Market Data Patterns and Industry Insights

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Market Size Increase Is Anticipated For The Biopsy Devices Market Over The 2026–2030 Period?

    The biopsy devices market size has seen substantial growth in recent years. It is forecast to increase from $3.24 billion in 2025 to $3.53 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.1%. The expansion observed in the past period is largely due to factors such as rising cancer screening rates, the proliferation of diagnostic imaging centers, a heightened use of biopsy procedures for early diagnosis, the availability of advanced imaging modalities, and improved hospital diagnostic capabilities.

    The biopsy devices market size is anticipated to undergo significant expansion in the coming years. It is projected to grow to $4.95 billion in 2030, achieving a compound annual growth rate (CAGR) of 8.8%. The increase during the forecast period is attributable to factors such as the increasing adoption of AI-assisted biopsy guidance, a rising demand for outpatient diagnostic procedures, the expansion of precision oncology practices, a growing emphasis on early disease detection, and increasing investments in advanced biopsy technologies. Major trends observed in the forecast period will involve the increasing integration of image-guided biopsy systems, a rising application of minimally invasive biopsy techniques, an expanding need for precision sampling devices, the proliferation of automated biopsy guidance technologies, and an enhanced commitment to diagnostic accuracy.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3283&type=smp

    What Drivers Are Expected To Influence The Biopsy Devices Market During The Forecast Period?

    An increasing volume of surgical procedures is projected to drive the expansion of the biopsy devices market. Surgery is a medical field dedicated to treating injuries, diseases, and various disorders through the application of both manual and instrumental methods. During surgical interventions, biopsy devices are frequently utilized to extract small tissue specimens or cell samples for subsequent laboratory analysis. For instance, according to the American Med Spa Association, a US-based provider of legal, compliance, and business resources for medical spas and medical aesthetic practices, cosmetic procedure volumes saw a rise of 42.5% over the past four years, reaching 20.5 million non-surgical treatments and 17.4 million surgical procedures in 2024, as reported in July 2025. Therefore, the growing number of surgeries is propelling the growth of the biopsy devices market ahead.

    How Is The Biopsy Devices Market Segmented Across Key Categories?

    The biopsy devices market covered in this report is segmented –

    1) By Product Type: Needle-Based Biopsy Guns, Biopsy Forceps, Biopsy Guidance Systems, Biopsy Needles, Other Products

    2) By Image Guiding Technology: MRI-Guided Biopsy, Stereotactic-Guided Biopsy, Ultrasound-Guided Biopsy, Other Imaging Technologies

    3) By Application: Breast Biopsy, Gynecological Biopsy, Prostate Biopsy, Blood Cancers Biopsy, Skin Biopsy, Kidney Biopsy, Gastroenterology Biopsy, Other Applications

    4) By End User: Diagnostics And Imaging Centers, Hospitals, Other End User

    Subsegments:

    1) By Needle-Based Biopsy Guns: Spring-Loaded Biopsy Guns, Vacuum-Assisted Biopsy Guns

    2) By Biopsy Forceps: Endoscopic Biopsy Forceps, Surgical Biopsy Forceps

    3) By Biopsy Guidance Systems: Ultrasound-Guided Biopsy Systems, CT-Guided Biopsy Systems, MRI-Guided Biopsy Systems

    4) By Biopsy Needles: Core Needles, Fine Needle Aspiration (FNA) Needles, Coaxial Needles

    5) By Other Products: Biopsy Sutures, Biopsy Markers, Biopsy Storage Solutions

    Which Upcoming Trends Are Expected To Influence The Biopsy Devices Market?

    Leading companies in the biopsy devices market are increasingly concentrating on developing advanced solutions, such as fine-needle biopsy precision technology, to improve diagnostic accuracy and sample quality. Fine-needle biopsy precision technology involves the creation of needles with specialized tips and durable materials designed to enhance tissue extraction while preserving cell architecture, thereby supporting reliable pathology analysis. For instance, in October 2025, Olympus, a Japan-based medical-technology company, introduced its SecureFlex single-use fine-needle biopsy device, featuring nitinol construction and a dual-beveled Raptor Tip. This tip facilitates the collection of larger, intact tissue specimens by minimizing tissue escape and improving puncture performance. The device’s construction also incorporates a multi-layer sheath, allowing consistent access to complex anatomical structures like the pancreatic head and uncinate process without frequent scope adjustments. SecureFlex supports fine-needle biopsy via EUS-FNB for gastrointestinal lesions, enabling physicians to obtain high-quality tissue for precise diagnosis and treatment planning. The device ultimately contributes to enhanced sample quality, procedural efficiency, and safety in endoscopic biopsy procedures.

    Who Are The Dominant Players Shaping The Biopsy Devices Market Landscape?

    Major companies operating in the biopsy devices market are Becton Dickinson and Company, Hologic Inc, Boston Scientific Corporation, Cook Medical LLC, Argon Medical Devices Inc, Olympus Corporation, Medtronic plc, Stryker Corporation, B Braun Melsungen AG, INRAD Inc, TSK Laboratory, Mauna Kea Technologies, Veran Medical Technologies, Merit Medical Systems Inc, ConMed Corporation, DTR Medical, Gallini Srl, TransMed7 LLC, MDL Srl, Biopsybell Srl

    Read the full biopsy devices market report here:

    https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

    Which Region Is Forecast To Lead The Biopsy Devices Market In Terms Of Market Size?

    North America was the largest region in the biopsy devices market in 2025. Asia-Pacific was the second largest region in the global biopsy devices market report share. The regions covered in the biopsy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Biopsy Devices Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=3283&type=smp

    Browse Through More Reports Similar to the Global Biopsy Devices Market 2026, By The Business Research Company

    Biopsy Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

    Smart Biopsy Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

    Liquid Biopsy Market Report 2026

    https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Biopsy Devices Industry Growth Insights: Revenue Forecast to 2030

    Biopsy Devices Industry Growth Insights: Revenue Forecast to 2030

    Uncover key drivers, emerging technologies, and competitive movements shaping the neurophotonics market from 2026–2035 with trusted insights from The Business Research Company

    What are the forecasted starting (2026) and ending (2030) market sizes for the Biopsy Devices Market?

    The biopsy devices market has observed substantial growth in recent years. It is anticipated to increase from $3.24 billion in 2025 to $3.53 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.1%. The expansion seen in previous periods can be linked to several factors including rising cancer screening rates, an increase in diagnostic imaging centers, the expanded application of biopsy procedures for early detection, the presence of advanced imaging technologies, and improved diagnostic capacities in hospitals.

    The biopsy devices market is projected to experience robust expansion over the coming years. This market is predicted to reach $4.95 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.8%. The anticipated growth during this period stems from factors such as the greater acceptance of AI-assisted biopsy guidance, a surge in demand for outpatient diagnostic procedures, the broadening scope of precision oncology practices, an elevated emphasis on early disease detection, and increased capital flowing into advanced biopsy technologies. Key trends expected during the forecast timeframe encompass the wider integration of image-guided biopsy systems, a growing preference for minimally invasive biopsy techniques, an escalating need for precision sampling devices, the proliferation of automated biopsy guidance technologies, and a heightened commitment to diagnostic accuracy.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3283&type=smp

    What Drivers Are Supporting Technological Adoption In The Biopsy Devices Market?

    An increasing volume of surgical procedures is anticipated to propel the expansion of the biopsy devices market. Surgery is a medical field dedicated to treating injuries, illnesses, and various disorders using both manual and instrumental methods. In these surgical contexts, biopsy devices are frequently employed to collect small tissue samples or cell clusters for subsequent laboratory analysis. For example, in July 2025, the American Med Spa Association, a US-based provider of legal, compliance, and business resources for medical spas and medical aesthetic practices, reported a 42.5% increase in cosmetic procedure volumes over the past four years, reaching 20.5 million non-surgical treatments and 17.4 million surgical procedures in 2024. Therefore, the growing number of surgeries is a key driver for the biopsy devices market’s growth moving forward.

    What Segment Types Are Examined In The Biopsy Devices Market?

    The biopsy devices market covered in this report is segmented –

    1) By Product Type: Needle-Based Biopsy Guns, Biopsy Forceps, Biopsy Guidance Systems, Biopsy Needles, Other Products

    2) By Image Guiding Technology: MRI-Guided Biopsy, Stereotactic-Guided Biopsy, Ultrasound-Guided Biopsy, Other Imaging Technologies

    3) By Application: Breast Biopsy, Gynecological Biopsy, Prostate Biopsy, Blood Cancers Biopsy, Skin Biopsy, Kidney Biopsy, Gastroenterology Biopsy, Other Applications

    4) By End User: Diagnostics And Imaging Centers, Hospitals, Other End User

    Subsegments:

    1) By Needle-Based Biopsy Guns: Spring-Loaded Biopsy Guns, Vacuum-Assisted Biopsy Guns

    2) By Biopsy Forceps: Endoscopic Biopsy Forceps, Surgical Biopsy Forceps

    3) By Biopsy Guidance Systems: Ultrasound-Guided Biopsy Systems, CT-Guided Biopsy Systems, MRI-Guided Biopsy Systems

    4) By Biopsy Needles: Core Needles, Fine Needle Aspiration (FNA) Needles, Coaxial Needles

    5) By Other Products: Biopsy Sutures, Biopsy Markers, Biopsy Storage Solutions

    Which Trends Are Shaping Activity Within The Biopsy Devices Market?

    Leading companies operating in the biopsy devices market are concentrating on developing advanced solutions, such as fine-needle biopsy precision technology, to enhance both diagnostic accuracy and sample quality. This fine-needle biopsy precision technology involves the engineering of needles with specialized tips and durable materials to improve tissue extraction while maintaining cellular architecture, thus supporting dependable pathology analysis. For instance, in October 2025, Olympus, a Japan-based medical-technology company, introduced its SecureFlex single-use fine-needle biopsy device, which features nitinol construction and a dual-beveled Raptor Tip. This tip assists in collecting larger, intact tissue specimens by minimizing tissue escape and improving puncture capabilities. The device’s construction includes a multi-layer sheath that allows for consistent access to complex anatomical structures like the pancreatic head and uncinate process without requiring frequent scope adjustments. SecureFlex supports fine-needle biopsy through EUS-FNB for gastrointestinal lesions, enabling physicians to obtain high-quality tissue for precise diagnosis and subsequent treatment planning. This device contributes to superior sample quality, increased procedural efficiency, and enhanced safety in endoscopic biopsy procedures.

    Who Are The Top-Performing Companies In The Biopsy Devices Market In Recent Years?

    Major companies operating in the biopsy devices market are Becton Dickinson and Company, Hologic Inc, Boston Scientific Corporation, Cook Medical LLC, Argon Medical Devices Inc, Olympus Corporation, Medtronic plc, Stryker Corporation, B Braun Melsungen AG, INRAD Inc, TSK Laboratory, Mauna Kea Technologies, Veran Medical Technologies, Merit Medical Systems Inc, ConMed Corporation, DTR Medical, Gallini Srl, TransMed7 LLC, MDL Srl, Biopsybell Srl

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

    Which Region Currently Holds The Largest Share Of The Biopsy Devices Market?

    North America was the largest region in the biopsy devices market in 2025. Asia-Pacific was the second largest region in the global biopsy devices market report share. The regions covered in the biopsy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Biopsy Devices Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=3283&type=smp

    Browse Through More Reports Similar to the Global Biopsy Devices Market 2026, By The Business Research Company

    Biopsy Devices Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

    Smart Biopsy Devices Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

    Liquid Biopsy Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

  • Global Biopsy Devices Market Size and Forecast to 2029: Revenue, Growth, and Trends

    Global Biopsy Devices Market Size and Forecast to 2029: Revenue, Growth, and Trends

    Uncover key drivers, emerging technologies, and competitive movements shaping the biopsy devices market from 2025–2034 with trusted insights from The Business Research Company

    How Big Is The Biopsy Devices Market Size Today And What Will Its Value Be At The End Of 2029?

    The biopsy devices market has shown strong growth in its size over recent years. It is anticipated to expand from $3.03 billion in 2024 to $3.24 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.9%. This past growth can be linked to the rise of emerging markets, improvements in healthcare infrastructure, and an increase in the elderly population.

    The biopsy devices market size is anticipated to demonstrate substantial growth over the coming years. It is projected to reach $4.56 billion by 2029, progressing at a compound annual growth rate (CAGR) of 9.0%. This expansion during the forecast period is primarily driven by government investments in the healthcare sector, an increase in cancer incidence, and rising healthcare expenditure. Notable trends expected during this period encompass technological advancements, the introduction of fully automatic biopsy systems, product innovations, the development of robot-assisted biopsy systems, partnerships and collaborations, and growing investments.

    Access A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3283&type=smp

    Which Key Drivers Are Powering Growth In The Biopsy Devices Market?

    The growing number of cancer instances has contributed to the expansion of the biopsy devices market. A biopsy serves as a primary method for medical professionals to diagnose bodily abnormalities when the presence of cancer cells is suspected. For example, in January 2023, the American Cancer Society, a US-based nationwide voluntary health organization dedicated to eliminating cancer, reported that approximately 1.9 million new cancer cases were projected to be diagnosed in the United States in 2022, alongside an estimated 609,360 cancer-related deaths. More specifically, about 151,030 new cases of colorectal cancer were expected to be identified by the end of 2022, with projections indicating roughly 52,550 deaths in 2023. Furthermore, in May 2022, the Canadian Medical Association Journal, a Canada-based peer-reviewed open-access general medical journal published by the Canadian Medical Association, stated in its report that an estimated 233,900 new cancer cases would be diagnosed in Canada during 2022. Among these, around 28,600 cases were anticipated to be breast cancer, accounting for approximately 25% of all new cancer diagnoses in women for that year. Lung cancer was predicted to be the most prevalent type of cancer in Canada in 2022, with an estimated 30,000 new cases.

    Which Segment Categories Are Driving Maximum Growth In The Biopsy Devices Market?

    The biopsy devicesmarket covered in this report is segmented –

    1) By Product Type: Needle-Based Biopsy Guns, Biopsy Forceps, Biopsy Guidance Systems, Biopsy Needles, Other Products

    2) By Image Guiding Technology: MRI-Guided Biopsy, Stereotactic-Guided Biopsy, Ultrasound-Guided Biopsy, Other Imaging Technologies

    3) By Application: Breast Biopsy, Gynecological Biopsy, Prostate Biopsy, Blood Cancers Biopsy, Skin Biopsy, Kidney Biopsy, Gastroenterology Biopsy, Other Applications

    4) By End User: Diagnostics And Imaging Centers, Hospitals, Other End User

    Subsegments:

    1) By Needle-Based Biopsy Guns: Spring-Loaded Biopsy Guns, Vacuum-Assisted Biopsy Guns

    2) By Biopsy Forceps: Endoscopic Biopsy Forceps, Surgical Biopsy Forceps

    3) By Biopsy Guidance Systems: Ultrasound-Guided Biopsy Systems, CT-Guided Biopsy Systems, MRI-Guided Biopsy Systems

    4) By Biopsy Needles: Core Needles, Fine Needle Aspiration (FNA) Needles, Coaxial Needles

    5) By Other Products: Biopsy Sutures, Biopsy Markers, Biopsy Storage Solutions

    What Key Trends Are Driving Growth In The Biopsy Devices Market?

    Robot-assisted biopsy systems are significantly impacting the biopsy devices market and are instrumental in preventing complications that can arise after a biopsy. These robotic procedures are employed to boost the precision and accuracy of the biopsy process, prompting medical authorities to approve the devices to streamline the procedure. For example, in July 2022, the FDA provided clearance for Siemens Healthineers’ and Intuitive’s platforms to establish a robotic-assisted platform specifically for minimally invasive lung biopsies. This advanced integration is set to enable 2D and 3D imaging during the procedures.

    Who Are The Leading Companies Driving The Biopsy Devices Market?

    Major companies operating in the biopsy devices market include Becton Dickinson and Company (BD), Hologic, Inc., Danaher Corporation, Boston Scientific Corporation, Olympus Corporation, Cook Medical, Medtronic Inc, Cardinal Health, Argon Medical Devices Inc., Fujifilm Holdings Corp, BMA Co. Ltd., Transmed (China) Co., LTD, HaploX Biotechnology, Gene+sLab, Lepu Medical Technology, CMR Naviscan Corporation, DDD Diagnostics, Philips Healthcare, Siemens Healthineers, Abbott Laboratories, Bangs Laboratories Inc, Roche Diagnostics, Cepheid, Devicor Medical Products, Braile Biomedica Ltd, B.Braun Medical Gulf, Stryker ESCS BV

    Download The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

    Which Region Holds The Largest Share In The Biopsy Devices Market Today?

    North America was the largest region in the biopsy devices market in 2024. Asia-Pacific was the second largest region in the global biopsy devices market report share. The regions covered in the biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Get A Report Customized For You Here:

    https://www.thebusinessresearchcompany.com/customise?id=3283&type=smp

    Browse Through More Reports Similar to the Global Biopsy Devices Market 2025, By The Business Research Company

    Liquid Biopsy Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

    Cell Cultures Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

    Cells Therapy Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Biopsy Devices Industry Trends: Where the Market Is Headed by 2029

    Global Biopsy Devices Industry Trends: Where the Market Is Headed by 2029

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    How Is The Biopsy Devices Market Size Likely To Evolve From 2025 Through 2034?

    The overall valuation of the biopsy devices sector has experienced robust expansion over the past few years, projected to climb from a value of $3.03 billion in 2024 to $3.24 billion by 2025, reflecting a steady compound annual growth rate (CAGR) pegged at 6.9%. This historical upward trend stems primarily from expansion within developing economies, concurrent improvements in medical facilities and infrastructure, alongside the increasing proportion of the senior demographic within the general population.

    The market for devices utilized in biopsies is projected to experience substantial expansion over the ensuing years, reaching a valuation of $4.56 billion by 2029, fueled by a compound annual growth rate (CAGR) of 9.0%; this upward trajectory during the forecasted period is fundamentally supported by increased governmental funding directed toward the medical field, a growing incidence of oncological diagnoses, and escalating overall spending on healthcare services, while key developments shaping this industry include continuous technological progression, the introduction of entirely automated biopsy apparatuses, ongoing product refinements, the creation of biopsy systems guided by robotics, strategic alliances and cooperative agreements, alongside amplified capital commitments.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3283&type=smp

    Which Drivers Are Shaping The Biopsy Devices Industry’s Market Share?

    Escalating cancer incidence has spurred expansion within the market for biopsy apparatus. Physicians frequently employ biopsies as a fundamental method to pinpoint bodily anomalies when malignancy is suspected. To illustrate this trend, the American Cancer Society, a US-based non-profit focused on eradicating cancer, reported in January 2023 that projections estimated the United States would see roughly 1.9 million new cancer diagnoses in 2022, accompanied by an anticipated 609,360 fatalities linked to the disease. Colorectal cancer, specifically, was forecasted to involve about 151,030 confirmations in new patients by the conclusion of 2022, with an expected death toll around 52,550 in 2023. Moreover, the Canadian Medical Association Journal, which is a Canadian, open-access, peer-reviewed publication from the Canadian Medical Association, noted in a May 2022 release that Canada anticipated approximately 233,900 new cancer diagnoses across 2022. Of this total, breast cancer cases were expected to number around 28,600, making up roughly a quarter of all new female cancer diagnoses that year. With an estimated 30,000 new instances, lung cancer was positioned as the most commonly detected cancer type in Canada during 2022.

    What Are The Primary Types Of Segments Analyzed In The Biopsy Devices Market?

    The biopsy devicesmarket covered in this report is segmented –

    1) By Product Type: Needle-Based Biopsy Guns, Biopsy Forceps, Biopsy Guidance Systems, Biopsy Needles, Other Products

    2) By Image Guiding Technology: MRI-Guided Biopsy, Stereotactic-Guided Biopsy, Ultrasound-Guided Biopsy, Other Imaging Technologies

    3) By Application: Breast Biopsy, Gynecological Biopsy, Prostate Biopsy, Blood Cancers Biopsy, Skin Biopsy, Kidney Biopsy, Gastroenterology Biopsy, Other Applications

    4) By End User: Diagnostics And Imaging Centers, Hospitals, Other End User

    Subsegments:

    1) By Needle-Based Biopsy Guns: Spring-Loaded Biopsy Guns, Vacuum-Assisted Biopsy Guns

    2) By Biopsy Forceps: Endoscopic Biopsy Forceps, Surgical Biopsy Forceps

    3) By Biopsy Guidance Systems: Ultrasound-Guided Biopsy Systems, CT-Guided Biopsy Systems, MRI-Guided Biopsy Systems

    4) By Biopsy Needles: Core Needles, Fine Needle Aspiration (FNA) Needles, Coaxial Needles

    5) By Other Products: Biopsy Sutures, Biopsy Markers, Biopsy Storage Solutions

    What Long-Term Trends Will Shape The Future Growth Of The Biopsy Devices Industry?

    Advancements in robotically assisted biopsy apparatus are significantly influencing the market for biopsy equipment, offering benefits such as the reduction of post-biopsy complications. These robotic systems are implemented specifically to boost both the exactness and reliability of the biopsy procedure, leading medical regulatory bodies to grant clearances for these tools to simplify the process. A notable illustration of this trend occurred in July 2022 when both the FDA authorized the combined utilization of platforms from Siemens Healthineers and Intuitive for carrying out minimally invasive lung biopsies via a robotic platform, a development that facilitates the simultaneous use of both two-dimensional and three-dimensional visualization throughout operations.

    Who Are The Core Companies Influencing The Biopsy Devices Market Landscape?

    Major companies operating in the biopsy devices market include Becton Dickinson and Company (BD), Hologic, Inc., Danaher Corporation, Boston Scientific Corporation, Olympus Corporation, Cook Medical, Medtronic Inc, Cardinal Health, Argon Medical Devices Inc., Fujifilm Holdings Corp, BMA Co. Ltd., Transmed (China) Co., LTD, HaploX Biotechnology, Gene+sLab, Lepu Medical Technology, CMR Naviscan Corporation, DDD Diagnostics, Philips Healthcare, Siemens Healthineers, Abbott Laboratories, Bangs Laboratories Inc, Roche Diagnostics, Cepheid, Devicor Medical Products, Braile Biomedica Ltd, B.Braun Medical Gulf, Stryker ESCS BV

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

    Which Region Is Projected To Lead The Biopsy Devices Market During The Forecast Period?

    North America was the largest region in the biopsy devices market in 2024. Asia-Pacific was the second largest region in the global biopsy devices market report share. The regions covered in the biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Request A Customized Version Of The Biopsy Devices Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=3283&type=smp

    Browse Through More Reports Similar to the Global Biopsy Devices Market 2025, By The Business Research Company

    Liquid Biopsy Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

    Cell Cultures Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

    Cells Therapy Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Key Factors Fueling the Growth of the Biopsy Devices Market in 2025: Rising Cancer Incidence Drives Robust Growth In The Biopsy Devices Market

    Key Factors Fueling the Growth of the Biopsy Devices Market in 2025: Rising Cancer Incidence Drives Robust Growth In The Biopsy Devices Market

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Fast Is The Biopsy Devices Market Expected to Grow Between 2025 And 2029?

    The market size for biopsy devices has significantly expanded in the last few years. A boost from $3.03 billion in 2024 to $3.24 billion in 2025 is projected, corresponding to a compound annual growth rate (CAGR) of 6.9%. Factors such as the development of emerging markets, improvements in healthcare infrastructure, and an increase in the older population have contributed to the previous period’s growth.

    It is anticipated that the biopsy devices market will experience a substantial increase in the coming years, reaching a value of $4.56 billion in 2029, with a compound annual growth rate (CAGR) of 9.0%. This expansion during the forecasted period can be traced back to factors such as government investment in the healthcare industry, an uptick in diagnosed cancer cases, and increased healthcare spending contributing to the market surge. Key trends expected during this period encompass technological growth, the introduction of fully automated biopsy systems, product improvements, progress in the field of robot-assisted biopsy systems, collaborations and partnerships, as well as escalated investments.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3283&type=smp

    What are the Fundamental Drivers and Innovations Shaping the Biopsy Devices Market?

    The increased occurrence of cancer has spurred growth in the biopsy devices market. Biopsies are often the first step doctors take when they suspect cancerous activity in the body. For example, in January 2023, the American Cancer Society – a voluntary health organization focused on eliminating cancer – predicted around 1.9 million new cancer diagnoses in the United States for 2022, with an expected 609,360 associated deaths. They expect around 151,030 of these will be new cases of colorectal cancer by end of 2022, potentially leading to about 52,550 deaths in 2023. The Canadian Medical Association Journal, a peer-reviewed general medical journal, reported in May 2022 that they anticipates approximately 233,900 new cancer diagnoses in Canada for 2022. They project around 28,600 of these cases will be breast cancer, accounting for around 25% of all new female cancer diagnoses for the year. The most common type of cancer expected in Canada for 2022 is lung cancer, with around 30,000 new cases predicted.

    How Is the Biopsy Devices Market Segmented?

    The biopsy devicesmarket covered in this report is segmented –

    1) By Product Type: Needle-Based Biopsy Guns, Biopsy Forceps, Biopsy Guidance Systems, Biopsy Needles, Other Products

    2) By Image Guiding Technology: MRI-Guided Biopsy, Stereotactic-Guided Biopsy, Ultrasound-Guided Biopsy, Other Imaging Technologies

    3) By Application: Breast Biopsy, Gynecological Biopsy, Prostate Biopsy, Blood Cancers Biopsy, Skin Biopsy, Kidney Biopsy, Gastroenterology Biopsy, Other Applications

    4) By End User: Diagnostics And Imaging Centers, Hospitals, Other End User

    Subsegments:

    1) By Needle-Based Biopsy Guns: Spring-Loaded Biopsy Guns, Vacuum-Assisted Biopsy Guns

    2) By Biopsy Forceps: Endoscopic Biopsy Forceps, Surgical Biopsy Forceps

    3) By Biopsy Guidance Systems: Ultrasound-Guided Biopsy Systems, CT-Guided Biopsy Systems, MRI-Guided Biopsy Systems

    4) By Biopsy Needles: Core Needles, Fine Needle Aspiration (FNA) Needles, Coaxial Needles

    5) By Other Products: Biopsy Sutures, Biopsy Markers, Biopsy Storage Solutions

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=3283&type=smp

    Which Regions Are Driving the Next Phase of the Biopsy Devices Market Growth?

    North America was the largest region in the biopsy devices market in 2024. Asia-Pacific was the second largest region in the global biopsy devices market report share. The regions covered in the biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    What Key Trends Are Shaping the Future of the Biopsy Devices Market?

    The biopsy devices market is being transformed by robot-assisted biopsy systems, which help prevent post-biopsy complications. The idea behind robot-assisted biopsies is to enhance the exactness and precision of the process and these devices have been approved by medical bodies to simplify the procedure. In an example from July 2022, the FDA cleared platforms from Siemens Healthineers and Intuitive for the creation of a robotic-assisted platform designed for minimally invasive lung biopsies. The merged system will facilitate both 2D and 3D imaging during operations.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

    How Is the Biopsy Devices Market Defined and What Are Its Core Parameters?

    The biopsy devices are used to extract sample cells or tissues from the patient’s body to be examined to determine the presence of a disease. They assist in diagnosing diseases, especially cancer, by enabling healthcare professionals to analyze cellular structures and identify abnormal or cancerous cells.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3283

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Biopsy Devices Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

    Biopsy Devices Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

    Discover trends, market shifts, and competitive outlooks for the biopsy devices industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

    How Fast Is The Biopsy Devices Market Expected to Grow Between 2025 And 2029?

    There has been significant growth recently in the size of the biopsy devices market. The expansion is expected to continue, with market size projected to rise from $3.03 billion in 2024 to $3.26 billion in 2025. This increase represents a compound annual growth rate (CAGR) of 7.7%. Factors contributing to this growth during historical times have included the development of emerging markets, improved healthcare infrastructure, and an increase in the older population.

    The market for biopsy devices is predicted to undergo significant growth in the upcoming years, reaching a value of $4.64 billion in 2029 with a compound annual growth rate (CAGR) of 9.2%. Influences stimulating this growth within the estimated period include governmental funding towards healthcare, the escalating occurrences of cancer, and an augmented healthcare expenditure. Key trends identified for this period encompass technological progress, the introduction of completely automated biopsy systems, innovative product development, the creation of biopsy systems supported by robotics, joint ventures, strategic alliances, and heightening financial inputs.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3283&type=smp

    How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theBiopsy Devices Market?

    The biopsy devices market has seen growth due to an increase in cancer cases. Biopsies are commonly employed by medical professionals to diagnose potential anomalies, particularly suspected cancer cells. In the context, the American Cancer Society, a leading US volunteer health organization focused on cancer eradication, indicated in January 2023 that roughly 1.9 million novel instances of cancer are predicted for diagnosis in the US during 2022, along with around 609,360 expected cancer-related fatalities. In particular, it is forecasted that nearly 151,030 new colorectal cancer cases will be discovered by the conclusion of 2022, leading to an estimated 52,550 deaths next year. Moreover, the Canadian Medical Association Journal — a Canada-based general medical journal that is peer-reviewed, open-access, and produced by the Canadian Medical Association — reported in May 2022 that around 233,900 new instances of cancer are predicted to be identified in Canada in 2022. This includes an approximate 28,600 projected cases of breast cancer, making up about 25% of all fresh cancer diagnoses in female patients that year. Lung cancer, with a estimated diagnosis of 30,000 new cases, is predicted to be the most common cancer variety in Canada for 2022.

    Which Segments in the Biopsy Devices Offer the Most Growth?

    The biopsy devices market covered in this report is segmented –

    1) By Product Type: Needle-Based Biopsy Guns, Biopsy Forceps, Biopsy Guidance Systems, Biopsy Needles, Other Products

    2) By Image Guiding Technology: MRI-Guided Biopsy, Stereotactic-Guided Biopsy, Ultrasound-Guided Biopsy, Other Imaging Technologies

    3) By Application: Breast Biopsy, Gynecological Biopsy, Prostate Biopsy, Blood Cancers Biopsy, Skin Biopsy, Kidney Biopsy, Gastroenterology Biopsy, Other Applications

    4) By End User: Diagnostics And Imaging Centers, Hospitals, Other End User

    Subsegments:

    1) By Needle-Based Biopsy Guns: Spring-Loaded Biopsy Guns, Vacuum-Assisted Biopsy Guns

    2) By Biopsy Forceps: Endoscopic Biopsy Forceps, Surgical Biopsy Forceps

    3) By Biopsy Guidance Systems: Ultrasound-Guided Biopsy Systems, CT-Guided Biopsy Systems, MRI-Guided Biopsy Systems

    4) By Biopsy Needles: Core Needles, Fine Needle Aspiration (FNA) Needles, Coaxial Needles

    5) By Other Products: Biopsy Sutures, Biopsy Markers, Biopsy Storage Solutions

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=3283&type=smp

    What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theBiopsy Devices Market?# Market?

    North America was the largest region in the biopsy devices market in 2024. Asia-Pacific was the second largest region in the global biopsy devices market report share. The regions covered in the biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    What Are the Current Market Growth and Trends in the Biopsy Devices Industry?

    The utilization of robot-assisted biopsy systems is transforming the biopsy devices market by aiding in the prevention of post-biopsy complications. These robotic systems are utilized to amplify the precision and correctness of the biopsy procedure, with regulatory bodies approving these devices to simplify the process. For example, the FDA gave clearance to Siemens Healthineers and Intuitive’s systems in July 2022. These platforms are designed to facilitate robot-assisted platforms for minimally invasive lung biopsies. This fusion of technology would enable both 2D and 3D imaging during the operations.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

    What Are the Key Elements That Define the Biopsy Devices Market?

    The biopsy devices are used to extract sample cells or tissues from the patient’s body to be examined to determine the presence of a disease. They assist in diagnosing diseases, especially cancer, by enabling healthcare professionals to analyze cellular structures and identify abnormal or cancerous cells.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3283

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Top Growth Trends in the Biopsy Devices Market: Insights into Market Size and Opportunities for 2025-2034

    Top Growth Trends in the Biopsy Devices Market: Insights into Market Size and Opportunities for 2025-2034

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theBiopsy Devices Market?

    The biopsy devices market has seen growth due to an increasing number of cancer cases. A biopsy, which is the main method used for diagnosing abnormalities when cancer cell presence is suspected, has become a critical tool in the fight against cancer. For example, in January 2023, the US-based American Cancer Society made a prediction that about 1.9 million new diagnoses of cancer are expected to occur in the United States in 2022, resulting in a predicted 609,360 cancer-related fatalities. Colorectal cancer specifically, is projected to have around 151,030 new cases by the conclusion of 2022, leading to an estimated 52,550 deaths in 2023. Moreover, in a May 2022 report by the Canadian Medical Association Journal, a peer-reviewed general medical journal based in Canada, projections suggest that nearly 233,900 new cancer cases will be identified in Canada in 2022. Of these, about 28,600 are poised to be breast cancer, making up roughly 25% of all new cancer diagnoses in women for that year. Lung cancer is predicted to be the most common cancer type in Canada in 2022, with an estimated new occurrence of 30,000 cases.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3283&type=smp

    How Has the Biopsy Devices Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?

    Over the previous years, the biopsy devices market has witnessed impressive growth. Predictions show that it will rise from $3.03 billion in 2024 to $3.26 billion in 2025, following a compound annual growth rate (CAGR) of 7.7%. The remarkable growth during the historic period is credited to the expansion of emerging markets, enhancements in healthcare infrastructure, and an increase in the aging population.

    The market size for biopsy devices is forecasted to experience a surge in the coming years, ballooning to $4.64 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 9.2%. This projected rise during the forecast period can be traced back to increased government funding in the health sector, a spike in the incidence of cancer, and a rise in health-related spending. Key trends that will shape this future scenario include the introduction of new technologies, the debut of fully automated biopsy systems, product enhancements, the progression of robotic-assisted biopsy systems, affiliations and partnerships, and enhanced financial backing.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3283

    What Are the Current Market Growth and Trends in theBiopsy Devices Market That Industry Players Should Watch?

    The biopsy devices market is being influenced by the advent of robot-assisted biopsy systems that help avert post-biopsy issues. Robot-assisted biopsies are performed to enhance the accuracy and precision of the procedure, and medical bodies have been approving these devices to simplify the process. For example, in July 2022, Siemens Healthineers’ and Intuitive’s platforms received clearance from the FDA for the creation of a robotic-assisted platform designed for minimally invasive lung biopsies. This advancement permits the use of 2D and 3D imaging throughout operations.

    What Are the Major Market Players Making an Impact on theBiopsy Devices Market Growth?

    Major companies operating in the biopsy devices market include Becton Dickinson and Company (BD), Hologic, Inc., Danaher Corporation, Boston Scientific Corporation, Olympus Corporation, Cook Medical, Medtronic Inc, Cardinal Health, Argon Medical Devices Inc., Fujifilm Holdings Corp, BMA Co. Ltd., Transmed (China) Co., LTD, HaploX Biotechnology, Gene+sLab, Lepu Medical Technology, CMR Naviscan Corporation, DDD Diagnostics, Philips Healthcare, Siemens Healthineers, Abbott Laboratories, Bangs Laboratories Inc, Roche Diagnostics, Cepheid, Devicor Medical Products, Braile Biomedica Ltd, B.Braun Medical Gulf, Stryker ESCS BV

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

    How Are the Key Segments of the Biopsy Devices Market Driving Opportunities and Innovations?

    The biopsy devices market covered in this report is segmented –

    1) By Product Type: Needle-Based Biopsy Guns, Biopsy Forceps, Biopsy Guidance Systems, Biopsy Needles, Other Products

    2) By Image Guiding Technology: MRI-Guided Biopsy, Stereotactic-Guided Biopsy, Ultrasound-Guided Biopsy, Other Imaging Technologies

    3) By Application: Breast Biopsy, Gynecological Biopsy, Prostate Biopsy, Blood Cancers Biopsy, Skin Biopsy, Kidney Biopsy, Gastroenterology Biopsy, Other Applications

    4) By End User: Diagnostics And Imaging Centers, Hospitals, Other End User

    Subsegments:

    1) By Needle-Based Biopsy Guns: Spring-Loaded Biopsy Guns, Vacuum-Assisted Biopsy Guns

    2) By Biopsy Forceps: Endoscopic Biopsy Forceps, Surgical Biopsy Forceps

    3) By Biopsy Guidance Systems: Ultrasound-Guided Biopsy Systems, CT-Guided Biopsy Systems, MRI-Guided Biopsy Systems

    4) By Biopsy Needles: Core Needles, Fine Needle Aspiration (FNA) Needles, Coaxial Needles

    5) By Other Products: Biopsy Sutures, Biopsy Markers, Biopsy Storage Solutions

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=3283&type=smp

    What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theBiopsy Devices Market?# Market Expansion?

    North America was the largest region in the biopsy devices market in 2024. Asia-Pacific was the second largest region in the global biopsy devices market report share. The regions covered in the biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Browse Through More Reports Similar to the Global Biopsy Devices Market 2025, By The Business Research Company:

    Medical Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/medical-equipment-global-market-report

    Cell Therapy Technologies Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

    Cell Based Assays Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Key Drivers and Opportunities in the Biopsy Devices Market: Insights into Trends and Growth

    Key Drivers and Opportunities in the Biopsy Devices Market: Insights into Trends and Growth

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What Long-Term Growth Rate is Expected for the Biopsy Devices Market Between 2025 and 2034?

    The biopsy devices market has witnessed strong growth in recent years. It is expected to expand from $3.03 billion in 2024 to $3.26 billion in 2025 at a CAGR of 7.7%. Key historical drivers include economic growth in emerging markets, advancements in healthcare infrastructure, and an aging population.

    The biopsy devices market is expected to grow to $4.64 billion by 2029 at a CAGR of 9.2%. This growth is supported by government investments in healthcare, rising cancer cases, and increasing healthcare expenditure. Major trends include technological advancements, the introduction of fully automatic biopsy systems, product innovations, the development of robot-assisted biopsy systems, partnerships, and increasing investments.

    Which Drivers Are Expected to Have the Greatest Impact on the biopsy devices Market’s Growth?

    The rising number of cancer cases is driving the growth of the biopsy devices market. Biopsy is a crucial diagnostic tool used by doctors to detect potential cancer cells. For example, in 2023, the American Cancer Society projected 1.9 million new cancer cases in the United States alone, signaling a growing need for biopsy procedures. As the number of cancer diagnoses increases, the demand for biopsy devices will continue to rise.

    Get Your Free Sample of the Global Biopsy Devices Market Report Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3283&type=smp

    What Are the Key Firms That Are Driving Transformation in the Biopsy Devices Market?

    Major companies operating in the biopsy devices market include:

    • Becton Dickinson and Company (BD)_x000D_

    • Hologic_x000D_

    • Inc._x000D_

    • Danaher Corporation_x000D_

    • Boston Scientific Corporation_x000D_

    What Current Trends in the Biopsy Devices Market Should Industry Players Pay Attention To?

    Robot-assisted biopsy systems are transforming the biopsy devices market, reducing complications post-biopsy. These systems enhance precision and accuracy, with regulatory bodies approving their use to streamline the process. For example, in July 2022, the FDA approved the integration of Siemens Healthineers’ and Intuitive’s platforms, enabling a robotic-assisted system for minimally invasive lung biopsies. This collaboration facilitates the use of both 2D and 3D imaging during procedures.

    Get Instant Access to the Global Biopsy Devices Market Report with Swift Delivery!

    https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

    Which Growth-Oriented Segments of the Biopsy Devices Market Are Leading the Industry’s Development?

    The biopsy devices market covered in this report is segmented –

    1) By Product Type: Needle-Based Biopsy Guns, Biopsy Forceps, Biopsy Guidance Systems, Biopsy Needles, Other Products

    2) By Image Guiding Technology: MRI-Guided Biopsy, Stereotactic-Guided Biopsy, Ultrasound-Guided Biopsy, Other Imaging Technologies

    3) By Application: Breast Biopsy, Gynecological Biopsy, Prostate Biopsy, Blood Cancers Biopsy, Skin Biopsy, Kidney Biopsy, Gastroenterology Biopsy, Other Applications

    4) By End User: Diagnostics And Imaging Centers, Hospitals, Other End User

    Subsegments:

    1) By Needle-Based Biopsy Guns: Spring-Loaded Biopsy Guns, Vacuum-Assisted Biopsy Guns

    2) By Biopsy Forceps: Endoscopic Biopsy Forceps, Surgical Biopsy Forceps

    3) By Biopsy Guidance Systems: Ultrasound-Guided Biopsy Systems, CT-Guided Biopsy Systems, MRI-Guided Biopsy Systems

    4) By Biopsy Needles: Core Needles, Fine Needle Aspiration (FNA) Needles, Coaxial Needles

    5) By Other Products: Biopsy Sutures, Biopsy Markers, Biopsy Storage Solutions

    What Regions Are Driving Expansion in the Biopsy Devices Market?

    North America was the largest region in the biopsy devices market in 2024. Asia-Pacific was the second largest region in the global biopsy devices market report share. The regions covered in the biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    What Key Parameters Define the Biopsy Devices Market’s Scope?

    The biopsy devices are used to extract sample cells or tissues from the patient’s body to be examined to determine the presence of a disease. They assist in diagnosing diseases, especially cancer, by enabling healthcare professionals to analyze cellular structures and identify abnormal or cancerous cells.

    Browse Through More Similar Reports By The Business Research Company:

    Medical Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/medical-equipment-global-market-report

    Cell Therapy Technologies Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

    Cell Based Assays Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: